These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 16289259)
1. Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma. Leiser AL; Anderson SE; Nonaka D; Chuai S; Olshen AB; Chi DS; Soslow RA Gynecol Oncol; 2006 Apr; 101(1):86-91. PubMed ID: 16289259 [TBL] [Abstract][Full Text] [Related]
2. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma. Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039 [TBL] [Abstract][Full Text] [Related]
3. [Expression of bcl-2 and bax protein in uterine leiomyosarcomas and leiomyomas]. Zhang ZL; Zhang Y; Zhou JH Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Apr; 30(2):183-6. PubMed ID: 15898430 [TBL] [Abstract][Full Text] [Related]
4. Cell cycle regulatory markers in uterine atypical leiomyoma and leiomyosarcoma: immunohistochemical study of 68 cases with clinical follow-up. Mills AM; Ly A; Balzer BL; Hendrickson MR; Kempson RL; McKenney JK; Longacre TA Am J Surg Pathol; 2013 May; 37(5):634-42. PubMed ID: 23552380 [TBL] [Abstract][Full Text] [Related]
5. Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma. Leitao MM; Soslow RA; Nonaka D; Olshen AB; Aghajanian C; Sabbatini P; Dupont J; Hensley M; Sonoda Y; Barakat RR; Anderson S Cancer; 2004 Sep; 101(6):1455-62. PubMed ID: 15316901 [TBL] [Abstract][Full Text] [Related]
6. Expression of thrombospondin 1 (TSP 1) in patients with uterine smooth muscle tumors: an immunohistochemical study. Bodner-Adler B; Nather A; Bodner K; Czerwenka K; Kimberger O; Leodolter S; Mayerhofer K Gynecol Oncol; 2006 Oct; 103(1):186-9. PubMed ID: 16595146 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of bcl-2 expression in leiomyosarcoma of the uterus. Zhai YL; Nikaido T; Toki T; Shiozawa A; Orii A; Fujii S Br J Cancer; 1999 Jul; 80(10):1658-64. PubMed ID: 10408415 [TBL] [Abstract][Full Text] [Related]
8. Expression of p16 protein in patients with uterine smooth muscle tumors: an immunohistochemical analysis. Bodner-Adler B; Bodner K; Czerwenka K; Kimberger O; Leodolter S; Mayerhofer K Gynecol Oncol; 2005 Jan; 96(1):62-6. PubMed ID: 15589581 [TBL] [Abstract][Full Text] [Related]
9. Altered expression of cell cycle regulatory proteins in gastrointestinal stromal tumors: markers with potential prognostic implications. Sabah M; Cummins R; Leader M; Kay E Hum Pathol; 2006 Jun; 37(6):648-55. PubMed ID: 16733203 [TBL] [Abstract][Full Text] [Related]
10. Expression of the O-linked N-acetylglucosamine containing epitope H in normal myometrium and uterine smooth muscle cell tumors. Sgantzos MN; Galani V; Arvanitis LD; Charchanti A; Psathas P; Nakou M; Havaki S; Kallioras V; Marinos E; Vamvakopoulos NC; Kittas C Pathol Res Pract; 2007; 203(1):31-7. PubMed ID: 17129677 [TBL] [Abstract][Full Text] [Related]
11. Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system. D'Angelo E; Spagnoli LG; Prat J Hum Pathol; 2009 Nov; 40(11):1571-85. PubMed ID: 19540555 [TBL] [Abstract][Full Text] [Related]
12. The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study. Akhan SE; Yavuz E; Tecer A; Iyibozkurt CA; Topuz S; Tuzlali S; Bengisu E; Berkman S Gynecol Oncol; 2005 Oct; 99(1):36-42. PubMed ID: 15992918 [TBL] [Abstract][Full Text] [Related]
13. Expression of Ki-67, P53 and progesterone receptors in uterine smooth muscle tumors. Diagnostic value. Petrović D; Babić D; Forko JI; Martinac I Coll Antropol; 2010 Mar; 34(1):93-7. PubMed ID: 20437637 [TBL] [Abstract][Full Text] [Related]
14. Long-term disease-free survival of patients with radically resected thymomas: relevance of cell-cycle protein expression. Mineo TC; Ambrogi V; Mineo D; Baldi A Cancer; 2005 Nov; 104(10):2063-71. PubMed ID: 16206298 [TBL] [Abstract][Full Text] [Related]
15. Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus: a comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p53 expression, DNA flow cytometry, and muscle specific actins. Amada S; Nakano H; Tsuneyoshi M Int J Gynecol Pathol; 1995 Apr; 14(2):134-42. PubMed ID: 8601525 [TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinases in patients with uterine smooth muscle tumors: an immunohistochemical analysis of MMP-1 and MMP-2 protein expression in leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma. Bodner-Adler B; Bodner K; Kimberger O; Czerwenka K; Leodolter S; Mayerhofer K J Soc Gynecol Investig; 2004 Apr; 11(3):182-6. PubMed ID: 15051038 [TBL] [Abstract][Full Text] [Related]
17. Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases. Mayerhofer K; Obermair A; Windbichler G; Petru E; Kaider A; Hefler L; Czerwenka K; Leodolter S; Kainz C Gynecol Oncol; 1999 Aug; 74(2):196-201. PubMed ID: 10419731 [TBL] [Abstract][Full Text] [Related]
18. Downregulation of cell cycle modulators p21, p27, p53, Rb and proapoptotic Bcl-2-related proteins Bax and Bak in cutaneous melanoma is associated with worse patient prognosis: preliminary findings. Tchernev G; Orfanos CE J Cutan Pathol; 2007 Mar; 34(3):247-56. PubMed ID: 17302609 [TBL] [Abstract][Full Text] [Related]